Briefing: BioNTech Shares Fall After Cofounders Plan Exit, Outlook Misses Forecasts
Strategic angle: BioNTech's stock takes a hit as cofounders announce their departure and the company's outlook fails to meet expectations.
Browse the full archive, newest first.